About the Authors

Katharina Kusejko

Roles Conceptualization, Data curation, Methodology, Software, Visualization, Writing – original draft, Writing – review & editing

katharina.kusejko@usz.ch (KK); Johannes.nemeth@usz.ch (JN)

Affiliations Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland, Institute of Medical Virology, University of Zurich, Zurich, Switzerland

Huldrych F. Günthard

Roles Conceptualization, Resources, Writing – review & editing

Affiliations Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland, Institute of Medical Virology, University of Zurich, Zurich, Switzerland

Gregory S. Olson

Roles Methodology, Writing – review & editing

Affiliation Seattle Children’s Research Institute, Seattle, Washington, United States of America

Kyra Zens

Roles Writing – review & editing

Affiliation Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland

Katharine Darling

Roles Writing – review & editing

Affiliation Department of Infectious Diseases, University Hospital Lausanne, Lausanne, Switzerland

Nina Khanna

Roles Writing – review & editing

Affiliation Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland

Hansjakob Furrer

Roles Writing – review & editing

Affiliation Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland

Pauline Vetter

Roles Writing – review & editing

Affiliation Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland

Enos Bernasconi

Roles Writing – review & editing

Affiliation Division of Infectious Diseases, Regional Hospital Lugano, Lugano, Switzerland

Pietro Vernazza

Roles Writing – review & editing

Affiliation Division of Infectious Diseases, Cantonal Hospital St Gallen, St. Gallen, Switzerland

Matthias Hoffmann

Roles Writing – review & editing

Affiliation Division of Infectious Diseases, Cantonal Hospital Olten, Olten, Switzerland

Roger D. Kouyos

Contributed equally to this work with: Roger D. Kouyos, Johannes Nemeth

Roles Conceptualization, Methodology, Resources, Writing – original draft, Writing – review & editing

Affiliations Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland, Institute of Medical Virology, University of Zurich, Zurich, Switzerland

Johannes Nemeth

Contributed equally to this work with: Roger D. Kouyos, Johannes Nemeth

Roles Conceptualization, Methodology, Project administration, Validation, Writing – original draft, Writing – review & editing

katharina.kusejko@usz.ch (KK); Johannes.nemeth@usz.ch (JN)

Affiliation Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland

the Swiss HIV Cohort Study

Membership of the the Swiss HIV Cohort Study is listed in the Acknowledgments.

Competing Interests

I have read the journal’s policy and the authors of this manuscript have the following competing interests: HFG has received unrestricted research grants from Gilead Sciences; fees for data and safety monitoring board or consulting/advisory board membership from Merck Gilead Sciences, ViiV, Sandoz and Mepha. The institution of HFG received unrestricted educational grants from ViiV, Gilead, MSD, abbvie, Sandoz and Pfizer paid to the institution. JN is supported by a Grant for Scientific Development from the University Hospital Zurich and by Swiss National Science Foundation grant#P300PB_164742. NK received travel grants, lecture fees and fees for advisory board meetings from MSD, Pfizer, and Gilead. Fees for advisory board meetings Janssen, and Basilea Pharmaceutica. She is a member of Data safety management board of Allecra Therapeutics SAS. KD’s institution has received research funding unrelated to this publication from Gilead and sponsorship to specialist meetings from MSD. NK received grants from the Swiss National Foundation during the conduct of the study which are not related to this study. The institution of EB received fees from Gilead Sciences, MSD, ViiV Healthcare, Pfizer, Abbvie and Sandoz for his participation to Advisory Boards and as travel grants. The authors KK, GSO, KZ, HF, PV, PV, MH and RDK have declared that no competing interests exist.